Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening.

about

Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening.

Item

http://www.wikidata.org/entity/Q49265752

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Epidemiological study of high- ...... in cervical cancer screening.

@en

Epidemiological study of high- ...... in cervical cancer screening.

@nl

type

Item

label

Epidemiological study of high- ...... in cervical cancer screening.

@en

Epidemiological study of high- ...... in cervical cancer screening.

@nl

prefLabel

Epidemiological study of high- ...... in cervical cancer screening.

@en

Epidemiological study of high- ...... in cervical cancer screening.

@nl

P1476

Epidemiological study of high- ...... in cervical cancer screening.

@en

P2093

Aifang Shen

http://www.w3.org/2001/XMLSchema#string

Jizeng Zheng

http://www.w3.org/2001/XMLSchema#string

Ran Du

http://www.w3.org/2001/XMLSchema#string

Shaocong Li

http://www.w3.org/2001/XMLSchema#string

Weizhi You

http://www.w3.org/2001/XMLSchema#string

P2860

A review of human carcinogens--Part B: biological agents

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.

Declining death rates reflect progress against cancer.

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)

Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.

P304

412-418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.5357

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29375696

http://www.w3.org/2001/XMLSchema#string

P932

5763653

http://www.w3.org/2001/XMLSchema#string